HRP Anti-DDB2 antibody [EPR9811],Abcam,AB205484

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human, Human

Application

IHC-P, WB

Conjugate

HRP

Platform ID

BAB089356382

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameHRP Anti-DDB2 antibody [EPR9811]
Cat. No.AB205484
HostRabbit
IsotypeIgG
ReactivityHuman, Human
ConjugationHRP
ApplicationIHC-P, WB
ClonalityMonoclonal
Clone NumberEPR9811
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.1% Proclin 300 Solution Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Protein, which is both involved in DNA repair and protein ubiquitination, as part of the UV-DDB complex and DCX (DDB1-CUL4-X-box) complexes, respectively (PubMed : 10882109, PubMed : 11278856, PubMed : 11705987, PubMed : 12732143, PubMed : 15882621, PubMed : 16473935, PubMed : 18593899, PubMed : 32789493, PubMed : 9892649). Core component of the UV-DDB complex (UV-damaged DNA-binding protein complex), a complex that recognizes UV-induced DNA damage and recruit proteins of the nucleotide excision repair pathway (the NER pathway) to initiate DNA repair (PubMed : 10882109, PubMed : 11278856, PubMed : 11705987, PubMed : 12944386, PubMed : 14751237, PubMed : 16260596, PubMed : 32789493). The UV-DDB complex preferentially binds to cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4 PP), apurinic sites and short mismatches (PubMed : 10882109, PubMed : 11278856, PubMed : 11705987, PubMed : 12944386, PubMed : 16260596). Also functions as the substrate recognition module for the DCX (DDB2-CUL4-X-box) E3 ubiquitin-protein ligase complex DDB2-CUL4-ROC1 (also known as CUL4-DDB-ROC1 and CUL4-DDB-RBX1) (PubMed : 12732143, PubMed : 15882621, PubMed : 16473935, PubMed : 18593899, PubMed : 26572825). The DDB2-CUL4-ROC1 complex may ubiquitinate histone H2A, histone H3 and histone H4 at sites of UV-induced DNA damage (PubMed : 16473935, PubMed : 16678110). The ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent DNA repair (PubMed : 16473935, PubMed : 16678110). The DDB2-CUL4-ROC1 complex also ubiquitinates XPC, which may enhance DNA-binding by XPC and promote NER (PubMed : 15882621). The DDB2-CUL4-ROC1 complex also ubiquitinates KAT7/HBO1 in response to DNA damage, leading to its degradation : recognizes KAT7/HBO1 following phosphorylation by ATR (PubMed : 26572825).. Isoform D1. Inhibits UV-damaged DNA repair.. Isoform D2. Inhibits UV-damaged DNA repair. See full target information DDB2

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.